Breaking News Instant updates and real-time market news.

IPAR

Inter Parfums

$47.00

-0.75 (-1.57%)

16:08
03/13/18
03/13
16:08
03/13/18
16:08

Inter Parfums reports Q4 adjusted EPS 14c, consensus 11c

Reports Q4 revenue $149.5M, consensus $149.6M. Gross margin was 66.1% compared to 63.7%. CEO Jean Madar says: "In 2017, we grew our footprint in all of our markets. North America became our largest market with year-over-year sales gains of 19%. Second place Western Europe grew sales by 8% as did our third largest market, Asia. Central and South America, the Middle East and Eastern Europe achieved comparable year sales growth of 16%, 21% and 20%, respectively. Regarding European based operations, our three largest brands all posted growth for the year, with Montblanc up 4%, Jimmy Choo up 20%, and Lanvin up 5%. In fact, in 2017, Jimmy Choo fragrance sales topped the $100 million mark joining Montblanc in that exclusive club. Our newer brands performed exceptionally well last year, with Coach and Rochas brand sales growing 149% and 34%, respectively, versus one year earlier. Of note, our first Coach fragrance only launched mid-2016, and today that brand is our fourth largest, which was achieved without a legacy fragrance business. As we've reported, we have several brand extensions launching this year, including Coach Floral and Lanvin Modern Princess Eau Sensuelle, both of which recently debuted, plus new extensions for Lanvin's Eclat d'Arpege and Coach for Men."

  • 14

    Mar

IPAR Inter Parfums
$47.00

-0.75 (-1.57%)

01/11/18
DADA
01/11/18
UPGRADE
Target $51
DADA
Buy
Inter Parfums upgraded to Buy at DA Davidson on momentum in French unit
As reported earlier, DA Davidson analyst Linda Bolton Weiser upgraded Inter Parfums to Buy from Neutral and raised her price target to $51 from $46. Weiser cites the company's French unit, which accounts for over 80% of sales, boosting its FY17 revenue outlook by EUR15M on strong year-end momentum at the firm's main brands. The analyst says Inter Parfums may report an upside sales surprise with Q4 earnings on January 29th and also expects the strength in the Coach for Men brand to carry into the first half of 2018.
01/22/18
SBSH
01/22/18
DOWNGRADE
Target $52
SBSH
Neutral
Inter Parfums downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Inter Parfums to Neutral citing valuation following the stock's recent rally. The analyst maintains a $52 price target for the shares, which she notes is based on the belief that Inter Parfums should trade at a 100% premium to the market.
01/22/18
KEYB
01/22/18
DOWNGRADE
KEYB
Sector Weight
Inter Parfums downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Jason Gere downgraded Inter Parfums to Sector Weight citing full valuation and lack of fundamental catalysts.
02/26/18
BWSF
02/26/18
NO CHANGE
Target $56
BWSF
Buy
Inter Parfums licensing deal with Guess affirms bull case, says BWS Financial
BWS Financial analyst Hamed Khorsand said Inter Parfums' (IPAR) licensing deal with Guess (GES) came as somewhat of a surprise, noting that the latter has been using Coty (COTY) for fragrances since 2010. This deal affirms his bull case that Inter Parfums management is not complacent and is looking for growth opportunities, said Khorsand, who added that he believes the company is still looking for more transactions like its acquisition of Rochas. He keeps a Buy rating and $56 price target on Inter Parfums.

TODAY'S FREE FLY STORIES

CX

Cemex

$4.85

-0.04 (-0.82%)

11:31
03/20/19
03/20
11:31
03/20/19
11:31
Hot Stocks
Cemex reaches agreement to divest white cement business for approx. $180M »

CEMEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

CONE

CyrusOne

$51.65

-0.06 (-0.12%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Conference/Events
CyrusOne management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 18

    Jun

VALE

Vale

$13.55

-0.15 (-1.09%)

11:30
03/20/19
03/20
11:30
03/20/19
11:30
Options
Delta neutral downside put block crossed firm to firm in Vale »

Delta neutral downside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

AMED

Amedisys

$124.56

-1.96 (-1.55%)

11:29
03/20/19
03/20
11:29
03/20/19
11:29
Conference/Events
Amedisys management to meet with Suntrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 28

    Mar

  • 29

    Mar

  • 02

    Apr

  • 03

    Apr

OBSV

ObsEva

$12.90

-0.07 (-0.54%)

11:26
03/20/19
03/20
11:26
03/20/19
11:26
Conference/Events
ObsEva management to meet with JPMorgan »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 27

    Mar

11:25
03/20/19
03/20
11:25
03/20/19
11:25
General news
Euro$ interest rate futures backed up »

Euro$ interest rate…

11:25
03/20/19
03/20
11:25
03/20/19
11:25
Conference/Events
JPMorgan SMid Cap biotech analyst to hold a group luncheon »

SMid-Cap Biotech Analysts…

DB

Deutsche Bank

$8.92

-0.125 (-1.38%)

11:20
03/20/19
03/20
11:20
03/20/19
11:20
Options
Defensive option play opened in Deutsche Bank »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$324.35

0.81 (0.25%)

, NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Recommendations
Biogen, Nightstar Therapeutics analyst commentary at Mizuho »

Biogen likely not done…

BIIB

Biogen

$324.35

0.81 (0.25%)

NITE

Nightstar Therapeutics

$25.35

0.075 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

FB

Facebook

$163.54

1.95 (1.21%)

11:19
03/20/19
03/20
11:19
03/20/19
11:19
Hot Stocks
Facebook announces Oculus Rift S launching Spring 2019 »

At Game Developers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
03/20/19
03/20
11:17
03/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Conference/Events
JPMorgan air/surface transport analyst to hold analyst/industry conference call »

Airfreight & Surface…

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
03/20/19
03/20
11:16
03/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URI

United Rentals

$115.84

-4.79 (-3.97%)

11:15
03/20/19
03/20
11:15
03/20/19
11:15
Options
United Rentals put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:12
03/20/19
03/20
11:12
03/20/19
11:12
Conference/Events
JPMorgan healthcare tech analyst to hold an analyst/industry conference call »

Healthcare Technology…

CGC

Canopy Growth

$47.83

1.75 (3.80%)

11:05
03/20/19
03/20
11:05
03/20/19
11:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$8.51

-0.195 (-2.24%)

11:03
03/20/19
03/20
11:03
03/20/19
11:03
Hot Stocks
Ford to invest over $850M to expand EV production capacity at Michigan plant »

Ford announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CMTL

Comtech

$21.65

-0.33 (-1.50%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Comtech receives $2.2M contract for Midia gas development project in Romania »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

F

Ford

$8.50

-0.205 (-2.36%)

11:01
03/20/19
03/20
11:01
03/20/19
11:01
Hot Stocks
Breaking Hot Stocks news story on Ford »

Ford to invest more than…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

T

AT&T

$30.47

-0.23 (-0.75%)

10:55
03/20/19
03/20
10:55
03/20/19
10:55
Conference/Events
Economic Club of Washington, D.C. to hold luncheon meeting »

Chairman & CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 24

    Apr

  • 26

    Apr

  • 20

    May

GOOG

Alphabet

$1,206.02

6.31 (0.53%)

, GOOGL

Alphabet Class A

$1,209.61

6.48 (0.54%)

10:53
03/20/19
03/20
10:53
03/20/19
10:53
Periodicals
Supreme Court orders new look at $8.5M Google settlement, Bloomberg says »

The U.S. Supreme Court…

GOOG

Alphabet

$1,206.02

6.31 (0.53%)

GOOGL

Alphabet Class A

$1,209.61

6.48 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

BFRA

Biofrontera

$11.88

(0.00%)

10:52
03/20/19
03/20
10:52
03/20/19
10:52
Hot Stocks
Biofrontera says Ameluz Phase 3 study met primary regulatory endpoint »

Biofrontera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$56.86

-0.1 (-0.18%)

10:50
03/20/19
03/20
10:50
03/20/19
10:50
Options
Aggressive call buyers in Qualcomm »

Aggressive call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

CYTK

Cytokinetics

$9.80

1.24 (14.49%)

10:47
03/20/19
03/20
10:47
03/20/19
10:47
Recommendations
Cytokinetics analyst commentary at Piper Jaffray »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIGR

UP Fintech

$0.00

(0.00%)

10:43
03/20/19
03/20
10:43
03/20/19
10:43
Syndicate
Breaking Syndicate news story on UP Fintech »

UP Fintech opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.